Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-07-25
2006-07-25
Goldberg, Jeanine A. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S287200, C536S023100, C536S024300
Reexamination Certificate
active
07081340
ABSTRACT:
The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. Th invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.
REFERENCES:
patent: 5563035 (1996-10-01), Weigel
patent: 6180333 (2001-01-01), Giordano
patent: 6316208 (2001-11-01), Roberts et al.
patent: 6331396 (2001-12-01), Silverman et al.
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/10436 (2002-02-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/083096 (2003-10-01), None
Bhattacharjee et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24, pp. 13790-13795 (2001).
Chen-Hsiang Yeang et al., “Molecular Classification of Multiple Tumor Types”, Bioinformatics, vol. 17, Suppl. 1, pp. S316-S322 (2001).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537 (1999).
Martin et al., “Linking Gene Expression Patterns to Therapeutic Groups in Breast Cancer”, Cancer Research, vol. 60, pp. 2232-2238 (2000).
Perou et al., “Molecular portraits of human breast tumors”, Nature, vol. 406, pp. 747-752 (2000).
Ramaswamy et al., “Multiclass cancer diagnosis using tumor gene expression signatures”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 26, pp. 15149-15154 (2001).
Sorlie et al., “Gene Expression patterns of breast carcinomas distinguish tumor subclass with clinical implications”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 19, pp. 10869-10874 (2001).
West et al., “Predicting the clinical status of human breast cancer by using gene expression profiles”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 20, pp. 11462-11467 (2001).
Yan et al., “Dissecting Complex Epigenetic Alterations in Breast Cancer Using CpG Island Microarrays”, Cancer Research, vol. 61, pp. 8375-7380 (2001).
Affymetrix Inc.: “Affymetrix GeneChip Human Genome U95 Version 2 Set HG-U95A,”GEO, XX, XX, 1-243 (2002).
Chang, J. et al., “Biologic Markers as Predictors of Clinical Outcome from Systemic Therapy for Primary Operable Breast Cancer,”Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 17:(10) 3058-3063 (1999).
Cox, G. et al., “Bcl-2 is an Independent Prognostic Factor and Adds to a Biological Model for Predicting Outcome in Operable Non-Small Cell Lung Cancer,”Lung Cancer, vol. 34:(3) 417-426 (2001).
Dijkema, I.M. et al., “Influence of p53 and bcl-2 on Proliferative Activity and Treatment Outcome in head and Neck Cancer Patients,”Oral Oncology, Elsevier Science, vol. 36:(1) 54-60 (2000).
Guerin, M. et al., “Structure and Expression of C-ERBB-2 and EGF Receptor Genes in Inflammatory and Non-Inflammatory Breast Cancer: Prognostic Significance,”International Journal of Cancer, vol. 43 201-208 (1989).
Joensuu, H. et al., “Bcl-2 Protein Expression and Long-Term Survival in Breast Cancer,”American Journal of Pathology, vol. 145:(5) 1191-1198 (1994).
Kymionis, G.D., et al., “Can Expression of Apoptosis Genes, bcl-2 and Bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?”The Journal of Surgical Research, vol. 99:(2) 161-168 (2001).
Locker, A.P. et al., “Ki67 Immunoreactivity in Breast Carcinoma: Relationships to prognostic Variable and Short time Survival,”Euroean Journal of Surgical Oncology, vol. 18:(3) 224-229 (1992).
Murray, P.A. et al., “The Prognostic Significance of Transforming Growth Factors in Human Breast Cancer,”British Journal of Cancer, vol. 67:(6) 1408-1412 (1993).
Sens, Mary Ann et al., “Metallothionein Isoform 3 Overexpression is Associated with Breast Cancers Having a Poor Prognosis,”American Journal of Pathology, vol. 159:(1) 21-26 (2001).
Specht K. et al., “Quantitative Gene Expression Analysis in Microdissected Archival Formalin-Fixed and Paraffin-Embedded Tumor Tissue,” 158:(2) 419-429 (2001).
Steinbach, Daniel et al., “Clinical Implications of PRAME Gene Expression in Childhood Acute Myeloid Leukemia,”Cancer Genetics and Cytogenetics, vol. 133:(2) 118-123 (2002).
Veer Van 'T.L.J. et al., “Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer,”Nature, Macmillan Journals Ltd., vol. 415:(6871) 530-536 (2002).
Baker Joffre B.
Cronin Maureen T.
Kiefer Michael C.
Shak Steve
Walker Michael Graham
Dreger Ginger R.
Genomic Health, Inc.
Goldberg Jeanine A.
Heller Ehrman LLP
LandOfFree
Gene expression profiling in biopsied tumor tissues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression profiling in biopsied tumor tissues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiling in biopsied tumor tissues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569309